TABLE OF CONTENTS 
1.0 INTRODUCTION 
2.0 OBJECTIVES 
3.0 PATIENT SELECTION 
4.0 PATIENT ENTRY 
5.0 TREATMENT REGIMEN 
6.0 STUDY PARAMETERS 
7.0 DRUG FORMULATION AND PROCUREMENT 
8.0 STATISTICS 
9.0 PATHOLOGY REVIEW 
10.0 RECORDS TO BE KEPT 
11.0 INFORMED CONSENT 
12.0 REFERENCES 
FIGURES 
1 - LNL-6 Vector 
2 - Virion Formation 
TABLES 
1 - ECOG Performance Status 
2 - ECOG Common Toxicity Criteria 
3 - Certificates of Analysis 
4 - Forms 
5 - Consent Form 
[466] 
Recombinant DNA Research, Volume 15 
